Announcements Trials
Browse Landscape

Status

Unknown 2Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

COVID-19 2Hematologic Neoplasms 1Chronic Disease 1

Interventions

Blood Specimen Collection 87Surveys and Questionnaires 86Surgical Procedures, Operative 45Drug Therapy 33Radiotherapy 28Biopsy 26Neoadjuvant Therapy 24Amplified Fragment Length Polymorphism Analysis 24Immunohistochemistry 22Gene Expression Profiling 21Bevacizumab 19Magnetic Resonance Spectroscopy 17Immunotherapy 17Data Collection 17Ultrasonography 16Positron Emission Tomography Computed Tomography 16Liquid Biopsy 16pembrolizumab 15Observation 15Nivolumab 15Watchful Waiting 14Radiosurgery 14Microarray Analysis 14Magnetic Resonance Imaging 14Interviews as Topic 14Immune Checkpoint Inhibitors 14Colonoscopy 13Capecitabine 13Polymerase Chain Reaction 12Paclitaxel 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Observational × BNT162 Vaccine × Clear all
NCT04743388 2022-04-11

Study of the Kinetics of Antibodies Against COVID-19 (SARS-CoV-2) and of Cellular Subpopulations of the Immune System

National and Kapodistrian University of Athens

Unknown
600 enrolled
Other hematologic neoplasm

COVID-19, Chronic Disease, Hematologic Neoplasms

NCT05119738 2022-02-02

Immune Response to Third Dose of SARS-CoV-2 Vaccine in a Cohort of Cancer Patients on Active Treatment

Pontificia Universidad Catolica de Chile

Unknown
122 enrolled

COVID-19

Data powered by HemOnc (CC BY 4.0) Colophon âš¡